| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylserine transfer activity | 1.67e-05 | 2 | 82 | 2 | GO:0140343 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 4.98e-05 | 3 | 82 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 2.47e-04 | 6 | 82 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 4.59e-04 | 8 | 82 | 2 | GO:0032453 | |
| Domain | TPR-contain_dom | 5.14e-05 | 150 | 82 | 6 | IPR013026 | |
| Domain | Hist_deacetylase_Gln_rich_N | 5.70e-05 | 3 | 82 | 2 | IPR024643 | |
| Domain | HDAC4_Gln | 5.70e-05 | 3 | 82 | 2 | PF12203 | |
| Domain | VDCC_T_a1 | 5.70e-05 | 3 | 82 | 2 | IPR005445 | |
| Domain | TPR-like_helical_dom | 7.38e-05 | 233 | 82 | 7 | IPR011990 | |
| Domain | TPR_REGION | 8.73e-05 | 165 | 82 | 6 | PS50293 | |
| Domain | TPR | 8.73e-05 | 165 | 82 | 6 | PS50005 | |
| Domain | Lys_sp_deMease-like_dom | 1.14e-04 | 4 | 82 | 2 | IPR013637 | |
| Domain | PLU-1 | 1.14e-04 | 4 | 82 | 2 | PF08429 | |
| Domain | Histone_deAcase_II_euk | 1.14e-04 | 4 | 82 | 2 | IPR017320 | |
| Domain | zf-C5HC2 | 1.89e-04 | 5 | 82 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 1.89e-04 | 5 | 82 | 2 | IPR004198 | |
| Domain | - | 3.00e-04 | 207 | 82 | 6 | 1.25.40.10 | |
| Domain | JmjN | 8.38e-04 | 10 | 82 | 2 | SM00545 | |
| Domain | JMJN | 8.38e-04 | 10 | 82 | 2 | PS51183 | |
| Domain | JmjN | 8.38e-04 | 10 | 82 | 2 | PF02375 | |
| Domain | VDCCAlpha1 | 8.38e-04 | 10 | 82 | 2 | IPR002077 | |
| Domain | HAT | 8.38e-04 | 10 | 82 | 2 | IPR003107 | |
| Domain | JmjN | 8.38e-04 | 10 | 82 | 2 | IPR003349 | |
| Domain | HAT | 8.38e-04 | 10 | 82 | 2 | SM00386 | |
| Domain | Hist_deacetyl | 1.02e-03 | 11 | 82 | 2 | PF00850 | |
| Domain | His_deacetylse_dom | 1.02e-03 | 11 | 82 | 2 | IPR023801 | |
| Domain | - | 1.02e-03 | 11 | 82 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 1.02e-03 | 11 | 82 | 2 | IPR000286 | |
| Domain | Oxysterol-bd | 1.22e-03 | 12 | 82 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 1.22e-03 | 12 | 82 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 1.22e-03 | 12 | 82 | 2 | PF01237 | |
| Domain | OSBP | 1.22e-03 | 12 | 82 | 2 | PS01013 | |
| Domain | - | 1.65e-03 | 391 | 82 | 7 | 2.30.29.30 | |
| Domain | - | 1.93e-03 | 15 | 82 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.93e-03 | 15 | 82 | 2 | SM00501 | |
| Domain | ARID_dom | 1.93e-03 | 15 | 82 | 2 | IPR001606 | |
| Domain | ARID | 1.93e-03 | 15 | 82 | 2 | PS51011 | |
| Domain | ARID | 1.93e-03 | 15 | 82 | 2 | PF01388 | |
| Domain | PH_dom-like | 2.67e-03 | 426 | 82 | 7 | IPR011993 | |
| Domain | TPR_repeat | 2.80e-03 | 133 | 82 | 4 | IPR019734 | |
| Domain | PH | 3.37e-03 | 229 | 82 | 5 | PF00169 | |
| Domain | JmjC | 4.94e-03 | 24 | 82 | 2 | PF02373 | |
| Domain | PH | 7.58e-03 | 278 | 82 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 7.69e-03 | 279 | 82 | 5 | PS50003 | |
| Pubmed | 1.28e-06 | 225 | 84 | 7 | 12168954 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33077627 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26206935 | ||
| Pubmed | FBXW10 promotes hepatocarcinogenesis in male patients and mice. | 5.76e-06 | 2 | 84 | 2 | 31400758 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26627919 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 37450367 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29748134 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27113756 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 28970484 | ||
| Pubmed | Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. | 5.76e-06 | 2 | 84 | 2 | 17988634 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PLEKHH1 ZNF462 AGO2 EPB41L4B VPS45 TUSC3 OSBPL5 TTC21B PPHLN1 CPD CHD1L CSMD1 LRRC8D ARAP1 | 1.25e-05 | 1489 | 84 | 14 | 28611215 |
| Pubmed | PI(4,5)P2 controls plasma membrane PI4P and PS levels via ORP5/8 recruitment to ER-PM contact sites. | 1.73e-05 | 3 | 84 | 2 | 29472386 | |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 1.73e-05 | 3 | 84 | 2 | 23488970 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 1.73e-05 | 3 | 84 | 2 | 18591418 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 1.73e-05 | 3 | 84 | 2 | 11230107 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 28846697 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 1.73e-05 | 3 | 84 | 2 | 28972185 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 33299036 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11927664 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 28418842 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 23297420 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 27353765 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11897840 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25776754 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 1.81e-05 | 468 | 84 | 8 | 31056421 | |
| Pubmed | ABCC1 AGO2 MBOAT7 P3H1 ALG9 OSBPL5 PEX16 OSBPL8 CPD PIGU LRRC8D CYFIP2 | 2.37e-05 | 1168 | 84 | 12 | 19946888 | |
| Pubmed | 2.62e-05 | 493 | 84 | 8 | 15368895 | ||
| Pubmed | 3.06e-05 | 504 | 84 | 8 | 34432599 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 34119632 | ||
| Pubmed | Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. | 3.45e-05 | 4 | 84 | 2 | 16541399 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 26822153 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 3.45e-05 | 4 | 84 | 2 | 28165634 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 10655483 | ||
| Pubmed | Class IIa histone deacetylases: conducting development and differentiation. | 3.45e-05 | 4 | 84 | 2 | 19412888 | |
| Pubmed | mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. | 3.45e-05 | 4 | 84 | 2 | 10748098 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 17360565 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.17e-05 | 857 | 84 | 10 | 25609649 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 15546868 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 15194749 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 37277019 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 20188095 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 19893013 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 18332106 | ||
| Pubmed | PLEKHH1 HDAC9 KDM5A CORO2A VPS45 ENPP2 ITSN1 OSBPL8 EIF3C ZFC3H1 CABIN1 DOP1B | 5.96e-05 | 1285 | 84 | 12 | 35914814 | |
| Pubmed | Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. | 8.59e-05 | 6 | 84 | 2 | 10825153 | |
| Pubmed | Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. | 8.59e-05 | 6 | 84 | 2 | 16356933 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 19351956 | ||
| Pubmed | 1.08e-04 | 101 | 84 | 4 | 9872452 | ||
| Pubmed | 1.17e-04 | 39 | 84 | 3 | 24709693 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 11022042 | ||
| Pubmed | A novel view of the transcriptome revealed from gene trapping in mouse embryonic stem cells. | 1.26e-04 | 40 | 84 | 3 | 17540781 | |
| Pubmed | Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. | 1.60e-04 | 8 | 84 | 2 | 17786239 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 12242305 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 28330839 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 17428193 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 34478646 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 1.60e-04 | 8 | 84 | 2 | 12761855 | |
| Pubmed | Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview | 1.68e-04 | 44 | 84 | 3 | 20301507 | |
| Pubmed | 2.04e-04 | 47 | 84 | 3 | 29617656 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 19621438 | ||
| Pubmed | Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. | 2.05e-04 | 9 | 84 | 2 | 11466315 | |
| Pubmed | ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. | 2.05e-04 | 9 | 84 | 2 | 21275903 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 15367668 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 12150997 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 16382099 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 32734583 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 16260608 | ||
| Pubmed | 2.49e-04 | 231 | 84 | 5 | 21048031 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 2.54e-04 | 363 | 84 | 6 | 14691545 | |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 12711221 | ||
| Pubmed | Isolation of novel mouse genes that were differentially expressed in W/W(V) mouse fundus. | 2.56e-04 | 10 | 84 | 2 | 15065000 | |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 24778262 | ||
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 28028172 | ||
| Pubmed | 2.86e-04 | 371 | 84 | 6 | 15747579 | ||
| Pubmed | 2.99e-04 | 529 | 84 | 7 | 14621295 | ||
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 31223056 | ||
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 11483621 | ||
| Pubmed | 3.20e-04 | 134 | 84 | 4 | 24324551 | ||
| Pubmed | 3.62e-04 | 57 | 84 | 3 | 18022353 | ||
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 32277911 | ||
| Pubmed | A family of 12 human genes containing oxysterol-binding domains. | 3.75e-04 | 12 | 84 | 2 | 11735225 | |
| Pubmed | Kinase signalling in excitatory neurons regulates sleep quantity and depth. | 3.75e-04 | 12 | 84 | 2 | 36477539 | |
| Pubmed | An oxysterol-binding protein family identified in the mouse. | 3.75e-04 | 12 | 84 | 2 | 12215260 | |
| Pubmed | 3.89e-04 | 730 | 84 | 8 | 34857952 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 24619213 | ||
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 4.64e-04 | 62 | 84 | 3 | 16147992 | |
| Pubmed | Histone deacetylase expression patterns in developing murine optic nerve. | 5.15e-04 | 14 | 84 | 2 | 25011550 | |
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 15601857 | ||
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 27399837 | ||
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 15964851 | ||
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 21953612 | ||
| Pubmed | Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. | 5.15e-04 | 14 | 84 | 2 | 15537544 | |
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 9151674 | ||
| Pubmed | 5.30e-04 | 963 | 84 | 9 | 28671696 | ||
| Pubmed | 5.57e-04 | 421 | 84 | 6 | 36976175 | ||
| Pubmed | 5.82e-04 | 157 | 84 | 4 | 30186101 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 12056414 | ||
| Pubmed | 6.09e-04 | 281 | 84 | 5 | 24163370 | ||
| GeneFamily | Histone deacetylases, class IIA | 5.04e-05 | 4 | 53 | 2 | 992 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.37e-04 | 206 | 53 | 5 | 682 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 4.56e-04 | 11 | 53 | 2 | 559 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 5.46e-04 | 12 | 53 | 2 | 670 | |
| GeneFamily | AT-rich interaction domain containing | 8.64e-04 | 15 | 53 | 2 | 418 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 2.23e-03 | 24 | 53 | 2 | 485 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.62e-03 | 26 | 53 | 2 | 253 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 2.19e-05 | 363 | 84 | 8 | M6315 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN | 2.60e-05 | 372 | 84 | 8 | MM1043 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP | 4.41e-05 | 199 | 84 | 6 | M6260 | |
| Coexpression | GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN | 4.54e-05 | 200 | 84 | 6 | M3499 | |
| Coexpression | GSE7852_TREG_VS_TCONV_UP | 4.54e-05 | 200 | 84 | 6 | M5751 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_DN | 4.54e-05 | 200 | 84 | 6 | M5674 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 1.48e-06 | 187 | 84 | 6 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-06 | 194 | 84 | 6 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 198 | 84 | 6 | 88b4662be9cc933a402c52673fa5e00fa979c0db | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-06 | 199 | 84 | 6 | f5c8ad751d21ea0b199a02846faecd04bf100033 | |
| ToppCell | severe-Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.18e-06 | 200 | 84 | 6 | f9af7e77a8483ab4ae708b55514e64f5420fa0c1 | |
| ToppCell | severe-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.18e-06 | 200 | 84 | 6 | f04d5951bac4dee47c22aaf7973312ca797f322e | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 2.18e-06 | 200 | 84 | 6 | fec2660c9a9977b3b3a2eaed063b9049c0b07ff2 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 1.66e-05 | 168 | 84 | 5 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.76e-05 | 170 | 84 | 5 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 1.86e-05 | 172 | 84 | 5 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 2.02e-05 | 175 | 84 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 2.38e-05 | 181 | 84 | 5 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-05 | 182 | 84 | 5 | d996ceb77c83591df4cef144ca72862f31d9777f | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 2.51e-05 | 183 | 84 | 5 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 2.57e-05 | 184 | 84 | 5 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.57e-05 | 184 | 84 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 2.64e-05 | 185 | 84 | 5 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.64e-05 | 185 | 84 | 5 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 185 | 84 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 187 | 84 | 5 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 187 | 84 | 5 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.78e-05 | 187 | 84 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 187 | 84 | 5 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.78e-05 | 187 | 84 | 5 | 75bc05a0ba2727fecc236903ace792a28f3d3c9a | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.78e-05 | 187 | 84 | 5 | a0d59bf1043ff5a1e8110b39ecc2d3932675edd4 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-05 | 188 | 84 | 5 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.85e-05 | 188 | 84 | 5 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.85e-05 | 188 | 84 | 5 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 2.93e-05 | 189 | 84 | 5 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | COVID-19_Severe-Myeloid_G-Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 2.93e-05 | 189 | 84 | 5 | a62f4c445ede00d15b74bee65f4e4fb54cfd4d32 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.93e-05 | 189 | 84 | 5 | f6b2b4824505f0119a017fdb73c55418fb651645 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.93e-05 | 189 | 84 | 5 | db8e314ce95c32542bb4015a77032a33211fea0b | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 2.93e-05 | 189 | 84 | 5 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.00e-05 | 190 | 84 | 5 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-05 | 191 | 84 | 5 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.08e-05 | 191 | 84 | 5 | b9b091d6b352d5128bb864ff52d2e5fb3387b766 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.23e-05 | 193 | 84 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.23e-05 | 193 | 84 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 193 | 84 | 5 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 193 | 84 | 5 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | severe-Myeloid-Neutrophils_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.32e-05 | 194 | 84 | 5 | 1f8edab1c8ba48bc0114429ea47aab378b5830b7 | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.32e-05 | 194 | 84 | 5 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.40e-05 | 195 | 84 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-05 | 195 | 84 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.40e-05 | 195 | 84 | 5 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-05 | 195 | 84 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 3.40e-05 | 195 | 84 | 5 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 3.40e-05 | 195 | 84 | 5 | 56f88ce95495260360bf08f9c76cc36e395dc6a9 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | 58b769da05a8f6b05aeb08d4f8b112941087ad00 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-05 | 196 | 84 | 5 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | mild-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.48e-05 | 196 | 84 | 5 | 9c351306b6aae68ed47d4cb1911957bf67f9e1ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 3.48e-05 | 196 | 84 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 197 | 84 | 5 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-05 | 197 | 84 | 5 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-05 | 197 | 84 | 5 | 340ce4fef244176fb52e38ffbcbdfda5ac3467dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 197 | 84 | 5 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.57e-05 | 197 | 84 | 5 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-05 | 197 | 84 | 5 | 928d70af7b990300be69a4debce6e66b556e5d9f | |
| ToppCell | COVID-19_Moderate-cDC|COVID-19_Moderate / disease group, cell group and cell class | 3.57e-05 | 197 | 84 | 5 | ff45a212434a1b128e1a217c6abdec6380938da9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 197 | 84 | 5 | 72cd61b868d57862ec9c230ea68913d3829b0f2b | |
| ToppCell | mild-Myeloid|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.65e-05 | 198 | 84 | 5 | 908746384e10c6b833bb3bc124045d7b0bfd73b5 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.65e-05 | 198 | 84 | 5 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | 002424b24dacac553e02d0f764a6e8a1e567b9df | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | e2d5c5cab102e67b0131b02392d81adaedc15965 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 3.83e-05 | 200 | 84 | 5 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.83e-05 | 200 | 84 | 5 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-05 | 200 | 84 | 5 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.83e-05 | 200 | 84 | 5 | a1f5684fe3815642159dd201b7ecc39f09bee1e8 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.83e-05 | 200 | 84 | 5 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 3.83e-05 | 200 | 84 | 5 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | severe-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | db7046741706376682d164c385c4701aebefc2e6 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.83e-05 | 200 | 84 | 5 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-05 | 200 | 84 | 5 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.47e-04 | 141 | 84 | 4 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 149 | 84 | 4 | 13b445c13bb8f31ff0876addd1baf969ae220ea3 | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 1.81e-04 | 149 | 84 | 4 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 2.01e-04 | 153 | 84 | 4 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.16e-04 | 156 | 84 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.22e-04 | 157 | 84 | 4 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 161 | 84 | 4 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 161 | 84 | 4 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 163 | 84 | 4 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 166 | 84 | 4 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 166 | 84 | 4 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-04 | 167 | 84 | 4 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.87e-04 | 168 | 84 | 4 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.87e-04 | 168 | 84 | 4 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 2.93e-04 | 169 | 84 | 4 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.07e-04 | 171 | 84 | 4 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 173 | 84 | 4 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 173 | 84 | 4 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 173 | 84 | 4 | b57d14e2c2368304cb903562d06ce8228f53857c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.28e-04 | 174 | 84 | 4 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-04 | 174 | 84 | 4 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| Drug | anacardic acid | 8.03e-08 | 30 | 84 | 5 | CID000167551 | |
| Drug | Chloroprene | ZNF462 HDAC9 ABCC1 ROPN1L TMTC1 RIN3 AGO2 PNLIPRP1 KDM5A CORO2A ST6GALNAC3 SMCHD1 PPHLN1 CPD EIF3C STIL ADGRL3 | 7.11e-06 | 1348 | 84 | 17 | ctd:D002737 |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 4.67e-05 | 4 | 83 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | cis-4-decenoylcarnitine (C10:1) measurement | 2.16e-04 | 8 | 83 | 2 | EFO_0800311 | |
| Disease | Liver Cirrhosis, Experimental | 3.27e-04 | 774 | 83 | 9 | C0023893 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 3.47e-04 | 10 | 83 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | serum selenium measurement | 4.54e-04 | 53 | 83 | 3 | EFO_0005266 | |
| Disease | decanoylcarnitine measurement | 5.07e-04 | 12 | 83 | 2 | EFO_0021039 | |
| Disease | ovarian carcinoma (is_implicated_in) | 8.02e-04 | 15 | 83 | 2 | DOID:4001 (is_implicated_in) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 9.14e-04 | 16 | 83 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 9.14e-04 | 16 | 83 | 2 | DOID:13207 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.25e-03 | 75 | 83 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 1.30e-03 | 19 | 83 | 2 | EFO_0002609, GO_0031427 | |
| Disease | phosphatidylethanolamine measurement | 1.46e-03 | 173 | 83 | 4 | EFO_0010228 | |
| Disease | feeling nervous measurement | 1.92e-03 | 87 | 83 | 3 | EFO_0009597 | |
| Disease | response to peginterferon alfa-2a | 2.25e-03 | 25 | 83 | 2 | EFO_0010103 | |
| Disease | psychosis predisposition measurement | 2.43e-03 | 26 | 83 | 2 | EFO_0008337 | |
| Disease | PR interval | 2.75e-03 | 495 | 83 | 6 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRYGSDPVFRFYHAY | 31 | Q7Z4L5 | |
| TYRDPLYEIVRKHIY | 171 | Q9H2P0 | |
| LRVPFLDHRFSSYYL | 416 | P08243 | |
| RDKPAYFAYRLYSAI | 246 | Q9UJ72 | |
| LSGFAFYLYKHRTRP | 3501 | Q96PZ7 | |
| SPAYAIRSYAYLLLH | 106 | Q9H6U8 | |
| FSKYRDFIRYLPIHL | 271 | Q5XX13 | |
| ESEHSRRKYFYLVGY | 961 | Q9HAR2 | |
| PDYKLRPYQHSYLRS | 316 | A1A5B4 | |
| HFLLIRNDYYIRPQY | 431 | O60879 | |
| APAYYAHLVAFRARY | 801 | Q9UKV8 | |
| SYFRLDTPLYFSYSH | 551 | Q32P28 | |
| FSKYRDFIRYLPIHL | 271 | O95170 | |
| RSFYAARDLYKYRHQ | 91 | Q5TC84 | |
| KRYLRHDKPPYTYLA | 26 | O75593 | |
| RRFPVLSYYYKDNHA | 186 | Q9Y216 | |
| RHPAQLLKSSYYYFF | 206 | Q8IUS5 | |
| YFYYKFRTRPSLLSA | 116 | Q6ZP29 | |
| SFLRSYYPCYLKVSH | 1321 | Q9Y3R5 | |
| ISRLLYYVFPYLRNH | 1926 | Q9Y3R5 | |
| YLYTRALTISPYHEK | 161 | Q9BVA6 | |
| HKTLYYDTDPFLFYV | 326 | Q92993 | |
| SLLRSHYERIIYPYE | 151 | Q9BY66 | |
| ALEKTYYERLPYRNH | 196 | Q69YN2 | |
| YPRSAYPSYLYIIHK | 331 | P41279 | |
| HLRSYKYYLESILNP | 281 | P54315 | |
| LQFAERYLRSYYHPT | 36 | P45452 | |
| YIYKSAPARSYVLRS | 331 | Q96N66 | |
| KALRDPTVTRRYYYS | 276 | O15230 | |
| KPLNIAYSHIYSSYR | 916 | Q96F07 | |
| HRFVRRLLYFYKPSS | 571 | Q6R327 | |
| RREYYLTHGLYLTAK | 411 | Q9H490 | |
| SLLKSHYERILYPYE | 156 | P29375 | |
| EPRSFLDKLSDYYYH | 431 | Q9BZF1 | |
| RIYLLRILHTYYKFD | 501 | Q99613 | |
| YASRLYLSRYQDTHP | 256 | Q96IJ6 | |
| SRFPQHYKSLYRLAF | 1521 | Q9Y6J0 | |
| YRLAFLYTYSKTHRN | 1531 | Q9Y6J0 | |
| KPYYSDYSRFRLLVH | 1591 | O43497 | |
| RLPYYATYCHTRLLI | 1466 | Q9P0X4 | |
| YSLPYKHTPYRVLRN | 286 | P51841 | |
| KVVYYRALYPFESRS | 741 | Q15811 | |
| KHLAARGIPTYIYYF | 861 | Q86WJ1 | |
| YIYYFPRSKSAVLHS | 871 | Q86WJ1 | |
| SHLPSLYDYSAYRRL | 281 | P10643 | |
| RYYEVSADKPHLSYL | 296 | Q92828 | |
| DFRFYITTKLRNPHY | 3076 | Q8WXX0 | |
| YRYHSYKDLSEFLRG | 931 | O75976 | |
| LDPKEHSYYYRPART | 36 | A4QMS7 | |
| PRFRYYLNKLHTFLS | 1231 | Q49AJ0 | |
| FYNDPSVLYISLHRY | 881 | Q9UQL6 | |
| FYADPSILYISLHRY | 831 | Q9UKV0 | |
| PYLDSFYEYSLKLLR | 381 | O00237 | |
| YALHFRVKYYSSEPN | 156 | Q9H329 | |
| YLRRRKYSLFAAFYS | 586 | O75923 | |
| RPPERYTSRYYLKFN | 261 | Q96CX2 | |
| FYSSHYARERSPYKR | 111 | Q8NEY8 | |
| RPAVLYRTRYDILYH | 601 | Q13822 | |
| YSKYFPYLALIHTII | 161 | Q7L1W4 | |
| YLLRSEPKRDFHFVY | 946 | Q8TB24 | |
| PRSFLNKLSDYYYHA | 396 | Q9H0X9 | |
| PFYFLYLSRHDRGYI | 51 | P33527 | |
| SYKPLVDLYSRRYFL | 106 | Q9NPI5 | |
| LLYYLLRSPFYDRFS | 281 | Q9Y5Y5 | |
| IIRYHPFLYDRETYP | 426 | A6NHR9 | |
| YKSQVFSYPHRYLVL | 116 | Q96HE8 | |
| AADLSLYPHLYSRAY | 101 | Q9H1J1 | |
| LYPHLYSRAYINFRN | 106 | Q9H1J1 | |
| SYTYRRPLRTHYGYI | 51 | Q8NDV1 | |
| RYLYFSSTKLRAPNY | 41 | Q9P0P8 | |
| EAKYREGKYRRYHPL | 641 | Q96P48 | |
| DFIYLHLSYYRNPKL | 41 | Q15468 | |
| SIFRSKYHGYPYSDL | 331 | Q13454 | |
| IHYNKTYVRDIYPFR | 2051 | Q8N2C7 | |
| EAIYHYRTALKLYPR | 501 | Q8IUR5 | |
| ARIPFKTFSYVYRYL | 161 | Q96C74 | |
| PVDSKRYRYVYHSSQ | 146 | Q9Y458 | |
| LRDFQSRLPYQYLHY | 136 | Q92791 | |
| SRLPYQYLHYALFKA | 141 | Q92791 | |
| PYHQPYISRKYFATR | 56 | Q6ZUI0 | |
| ERVARIYKHPFYNLY | 896 | Q7Z410 | |
| NYYKHKYPRPRDTSF | 66 | Q9BRT2 | |
| SFLSQYRYYTPAKRK | 251 | Q9P0W8 | |
| LRRPKYTIYFIYFSN | 86 | Q9NRW7 | |
| GKIFYYYRSHEDKRP | 711 | Q9ULM0 | |
| NAHLTYKFLTPYLYD | 346 | Q86WT1 | |
| SYTSPYFYALRKHIK | 1271 | Q96JM2 | |
| RLHIPRFYLFYDLST | 316 | O60603 | |
| LPGFYHLRIAYYASK | 91 | Q96A57 | |
| LVFKSYRFSPYYRTK | 1151 | O60293 | |
| YDRSKTSARIYPTYH | 531 | Q9UQQ1 |